IMPAX Laboratories, Inc. (IPXL) Launches Generic Solaraze® (Diclofenac Sodium Gel, 3%)
11/21/2013 11:30:07 AM
HAYWARD, Calif.--(BUSINESS WIRE)--Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it is commencing shipment of generic Solaraze® (diclofenac sodium gel, 3%), a first-to-file product, through Global Pharmaceuticals, Impax’s generics division.
Help employers find you! Check out all the jobs and post your resume.
comments powered by